Globeflex Capital L P lifted its holdings in HealthSouth Corporation (NYSE:HLS) by 12.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,758 shares of the company’s stock after buying an additional 2,288 shares during the period. Globeflex Capital L P’s holdings in HealthSouth Corporation were worth $1,005,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of HLS. Wellington Management Group LLP boosted its position in HealthSouth Corporation by 4,377.7% during the first quarter. Wellington Management Group LLP now owns 995,082 shares of the company’s stock valued at $42,599,000 after purchasing an additional 972,859 shares during the last quarter. Mackay Shields LLC acquired a new stake in HealthSouth Corporation during the second quarter valued at $39,641,000. TimesSquare Capital Management LLC acquired a new stake in HealthSouth Corporation during the second quarter valued at $37,868,000. William Blair Investment Management LLC boosted its position in HealthSouth Corporation by 13.9% during the second quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock valued at $208,253,000 after purchasing an additional 525,767 shares during the last quarter. Finally, Marshall Wace North America L.P. boosted its position in HealthSouth Corporation by 311.3% during the second quarter. Marshall Wace North America L.P. now owns 560,568 shares of the company’s stock valued at $26,907,000 after purchasing an additional 424,280 shares during the last quarter. 93.04% of the stock is owned by institutional investors and hedge funds.
WARNING: “HealthSouth Corporation (HLS) Stake Increased by Globeflex Capital L P” was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2017/09/26/healthsouth-corporation-hls-stake-increased-by-globeflex-capital-l-p.html.
In other news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company’s stock.
A number of analysts recently issued reports on HLS shares. Zacks Investment Research cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 3rd. ValuEngine cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Stephens started coverage on HealthSouth Corporation in a research report on Thursday, August 31st. They set an “overweight” rating and a $53.00 price objective for the company. Royal Bank Of Canada reissued a “buy” rating and set a $55.00 price objective on shares of HealthSouth Corporation in a research report on Wednesday, September 6th. Finally, BidaskClub cut HealthSouth Corporation from a “hold” rating to a “sell” rating in a research report on Thursday, July 13th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the stock. HealthSouth Corporation has an average rating of “Hold” and an average target price of $49.71.
HealthSouth Corporation (NYSE HLS) opened at 44.82 on Tuesday. The firm’s 50-day moving average price is $44.26 and its 200 day moving average price is $44.95. The company has a market capitalization of $4.43 billion, a price-to-earnings ratio of 16.33 and a beta of 0.59. HealthSouth Corporation has a 12-month low of $36.97 and a 12-month high of $49.71.
HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. During the same period in the prior year, the business posted $0.69 EPS. The company’s quarterly revenue was up 6.6% on a year-over-year basis. On average, equities research analysts expect that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Monday, October 2nd will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.23%. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Friday, September 29th. HealthSouth Corporation’s dividend payout ratio is currently 35.29%.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.